These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 15002324)

  • 21. Calcium antagonists as a peripherally acting labyrinthine suppressant in humans.
    Mangabeira-Albernaz PL
    Acta Otolaryngol Suppl; 1988; 460():99-103. PubMed ID: 3074621
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The possible mechanisms of the antioxidant action of calcium channel blockers in the hypoxic syndrome].
    Savchenko LV; Dzuban EM; Luk'ianchuk VD
    Eksp Klin Farmakol; 1996; 59(2):53-5. PubMed ID: 8974568
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Cerebral protective effects by continuous administration of a calcium antagonist after canine global brain ischemia--change in cerebral blood flow and metabolism].
    Ono K; Iwatsuki N; Obara S; Hashimoto Y
    Masui; 1988 Jan; 37(1):23-8. PubMed ID: 3367498
    [No Abstract]   [Full Text] [Related]  

  • 24. [Betaserc in the treatment of vestibular disorders in vascular dystonia syndrome].
    Putilina MV; Kuznetsova IuI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2004; 104(11):58-60. PubMed ID: 15581039
    [No Abstract]   [Full Text] [Related]  

  • 25. Effects of dipfluzine on cortical somatosensory evoked potentials and amino acid contents in ischemic rat brain.
    Wang YL; He RR
    Zhongguo Yao Li Xue Bao; 1996 Jan; 17(1):41-4. PubMed ID: 8737451
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The use of beta-interferon-1b in children and adolescents with multiple sclerosis].
    Bykova OV; Kuzenkova LM; Maslova OI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2006; 106(9):29-33. PubMed ID: 17069059
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Calcium antagonists and cerebrovascular circulation].
    De Gregorio C
    Clin Ter; 1987 Oct; 123(1):41-50. PubMed ID: 2972466
    [No Abstract]   [Full Text] [Related]  

  • 28. Therapy of chronic consequences of brain ischemia. Comparison between two drugs acting on brain circulation and metabolism.
    Passeri M
    Eur Neurol; 1978; 17 Suppl 1():150-8. PubMed ID: 381005
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Betaferon in the treatment of multiple sclerosis: efficacy standards].
    Totolian NA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2005; 105(7):63-6. PubMed ID: 16117152
    [No Abstract]   [Full Text] [Related]  

  • 30. [Experimental studies on pharmacologic protection of the brain against focal ischemia. 2. Effects of KB-2796 and nicardipine on focal brain ischemia in rats].
    Shiino A
    Nihon Geka Hokan; 1989 Sep; 58(5):438-44. PubMed ID: 2642267
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Interferon beta and copolymer-1: mechanism of action and clinical effects in multiple sclerosis].
    Losy J
    Neurol Neurochir Pol; 2000; 34(3 Suppl):63-9. PubMed ID: 10983302
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Agents to improve cerebrovascular circulation and cerebral metabolism--calcium antagonists].
    Kyoi K; Utsumi S
    Nihon Rinsho; 1985 Feb; 43(2):368-71. PubMed ID: 3889411
    [No Abstract]   [Full Text] [Related]  

  • 33. [Interferons beta in patients with multiple sclerosis].
    Vlasov IaV; Kuznetsova NI; Poverennova IE; Khivintseva EV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2005; 105(7):54-5. PubMed ID: 16117149
    [No Abstract]   [Full Text] [Related]  

  • 34. Can blood gene expression predict which patients with multiple sclerosis will respond to interferon?
    Kaminski N; Achiron A
    PLoS Med; 2005 Feb; 2(2):e33; quiz e51. PubMed ID: 15736992
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of intracerebroventricular endothelin-1 on CNS and cerebral hypoxia/ischemia and their modification by cinnarizine.
    Nikolov R; Maslarova J; Semkova I
    Methods Find Exp Clin Pharmacol; 1992 Oct; 14(8):577-83. PubMed ID: 1494299
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Cerebral circulation and calcium antagonists].
    Uematsu D; Fukuuchi Y
    No To Shinkei; 1990 Jan; 42(1):17-31. PubMed ID: 2186763
    [No Abstract]   [Full Text] [Related]  

  • 37. Interferon beta-1b inhibits gelatinase secretion and in vitro migration of human T cells: a possible mechanism for treatment efficacy in multiple sclerosis.
    Leppert D; Waubant E; Bürk MR; Oksenberg JR; Hauser SL
    Ann Neurol; 1996 Dec; 40(6):846-52. PubMed ID: 9007089
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical efficacy and safety of long-term immunomodulating therapy with interferon beta].
    Demina TL; Khachanova NV; Davydovskaia MV; Popova NF; Gusev EI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(4):24-6. PubMed ID: 18567192
    [No Abstract]   [Full Text] [Related]  

  • 39. The combined effect of cinnarizine and domperidone on vestibular susceptibility.
    Oosterveld WJ
    Aviat Space Environ Med; 1987 Mar; 58(3):218-23. PubMed ID: 3495259
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Basic principles of cerebral protection in humans.
    Lanier WL
    Liver Transpl Surg; 1999 Jul; 5(4):347-9. PubMed ID: 10388512
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.